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ARTICLE
Internalized TSH receptors en route to the TGN
induce local Gs-protein signaling and gene
transcription
Amod Godbole1,2, Sandra Lyga1,2, Martin J. Lohse1,2,5 & Davide Calebiro 1,2,3,4
A new paradigm of G-protein-coupled receptor (GPCR) signaling at intracellular sites has
recently emerged, but the underlying mechanisms and functional consequences are insufﬁ-
ciently understood. Here, we show that upon internalization in thyroid cells, endogenous TSH
receptors trafﬁc retrogradely to the trans-Golgi network (TGN) and activate endogenous
Gs-proteins in the retromer-coated compartment that brings them to the TGN. Receptor
internalization is associated with a late cAMP/protein kinase A (PKA) response at the Golgi/
TGN. Blocking receptor internalization, inhibiting PKA II/interfering with its Golgi/TGN
localization, silencing retromer or disrupting Golgi/TGN organization all impair efﬁcient TSH-
dependent cAMP response element binding protein (CREB) phosphorylation. These results
suggest that retrograde trafﬁcking to the TGN induces local Gs-protein activation and cAMP/
PKA signaling at a critical position near the nucleus, which appears required for efﬁcient CREB
phosphorylation and gene transcription. This provides a new mechanism to explain the
functional consequences of GPCR signaling at intracellular sites and reveals a critical role for
the TGN in GPCR signaling.
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G-protein-coupled receptors (GPCRs) constitute the largestfamily of receptors for hormones and neurotransmitters1,2. They are implicated in several human diseases and are
major pharmacological targets3. For all these reasons, their sig-
naling mechanisms have been intensively investigated.
Signaling by GPCRs is initiated by binding of an agonist to a
receptor1, 2, 4. The ensuing conformational change in the receptor
is then relayed via activation of heterotrimeric G-proteins to
effectors located at the cell membrane1, 2, 4. Among these, ade-
nylyl cyclases play a major role in GPCR signaling by generating
the soluble second messenger cyclic AMP (cAMP), which is
implicated in the regulation of a plethora of cellular functions,
such as gene transcription and cell proliferation1, 2, 4. These
effects of cAMP are mediated by activation of cAMP effectors,
which include guanine nucleotide exchange proteins activated by
cAMP (Epac), cyclic nucleotide-gated ion channels and protein
kinase A (PKA)5. In particular, the translocation of PKA catalytic
subunit to the nucleus in response to GPCR activation regulates
gene transcription via phosphorylation of transcription factors of
the cAMP response element binding protein (CREB)/activating
transcription factor family6. Although cAMP is a small diffusible
molecule, it has been hypothesized that cAMP/PKA signaling is
compartmentalized such that cAMP and/or PKA would exert
their effects only close to their site of production/activation5, 7–11.
While this hypothesis is consistent with a number of experi-
mental observations, a direct proof that cAMP/PKA micro-
compartments are involved in GPCR signaling is still missing5, 9.
Although several GPCRs rapidly internalize upon agonist sti-
mulation and trafﬁc through various intracellular compartments,
signaling by GPCRs has long been believed to occur only at the
cell surface. The only exception was represented by the G-
protein-independent and β-arrestin-dependent activation of the
mitogen-activated protein kinase pathway, which was shown to
happen also on endosomal membranes12. However, recent
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Fig. 1 TSH/TSHR complexes trafﬁc retrogradely to the TGN. Primary mouse thyroid cells were stimulated with ﬂuorescent TSH (TSH-594 or TSH-647) for
10min to visualize internalized TSH/TSHR complexes. When indicated, the cells were previously transfected with different combinations of subcellular
markers. Shown are images at the indicated time points from beginning of stimulation. a Representative images of non-transfected cells obtained before
stimulation and at 10 min, showing TSH bound to the plasma membrane and inside intracellular vesicles. The focus in the images shown in a was
speciﬁcally set to also visualize TSH at the plasma membrane (arrowheads). b Simultaneous visualization of the early endosome marker Rab5-GFP and
TSH-594. Representative images of the same cell obtained before and 10min after stimulation are shown. Insets correspond to the regions marked with
white boxes. c Time series showing accumulation of TSH-647 with the TGN-marker ST-RFP. White pixels in co-localization images indicate regions where
TSH-647 and ST-RFP were simultaneously present. d Quantiﬁcation showing the percentage (mean± s.e.m.; n= 14 cells) of TSH-containing structures co-
localizing with ST-RFP over time, calculated from images like those in c. e Enlarged view of the region delimited by the white box in c, showing individual
fusion events (arrowheads). Time is given relative to the ﬁrst image. f Simultaneous visualization of transfected TSHR-YFP, ST-RFP (blue) and TSH-647.
Shown is a representative image acquired 30min after stimulation. Inset corresponds to the region marked with the white box. White indicates triple co-
localization. Arrowheads point to TSH/TSHR complexes in vesicles and tubules of the TGN. Where appropriate, cell edges and nucleus (N) are marked in
white. Data in a–c and f are representative of 3, 3, 4 and 3 independent experiments, respectively
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Fig. 2 Internalized TSH/TSHRs meet the Gs-protein at the retromer-coated compartment (RCC) associated with the TGN. Primary mouse thyroid cells
were cotransfected with different combinations of Gs-YFP and/or subcellular markers, followed by stimulation with ﬂuorescent TSH (TSH-594 or TSH-
647) for 10 min to visualize internalized TSH/TSHR complexes. Shown are images at the indicated time points from beginning of stimulation. a Co-
localization between TSH-594 and transfected Gs-YFP at 10min. The focus in the images shown in a was speciﬁcally set to also visualize TSH and the Gs-
protein at the plasma membrane (arrowheads). b Co-localization between TSH-647, Gs-YFP and the early endosome marker Rab5-mCherry. Note the
absence of triple co-localization after TSH stimulation. c Co-localization between TSH-594 and Gs-YFP. TSH is co-localizing with the Gs-protein on
subdomains of tubulovesicular structures concentrated around the nucleus (arrowheads). d Quantiﬁcation showing the percentage (mean± s.e.m.; n= 10
cells) of TSH-containing structures co-localizing with Gs-YFP over time, calculated from images like those in c. e Enlarged view of a typical elongated
membranous structure, showing presence of the Gs-protein on only one side and TSH on both. f Image sequences showing polarized fusion/splitting
events among TSH- and Gs-protein-containing structures. Time is given relative to the ﬁrst image. g Simultaneous visualization of TSH-647, Gs-YFP and
Vps29-mCherry, used to localize the retromer complex. Structures analogous to those reported in c were observed (arrowheads). Bottom Enlarged view of
a typical elongated membranous structure demonstrating the presence of retromer on the Gs-positive subdomain. h Quantiﬁcation showing the percentage
(mean± s.e.m.; n= 4 cells) of structures containing both TSH-647 and Gs-YFP co-localizing with Vps29-mCherry over time, calculated from images like
those in g. i Schematic view of the results. Where appropriate, cell edges and nucleus (N) are marked in white. Data in a–c and g are representative of 3, 3,
5 and 3 independent experiments, respectively
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ﬁndings have challenged this classical model of GPCR signaling
by suggesting that internalized GPCRs can activate G-protein-
dependent pathways at intracellular sites13–21.
The ﬁrst direct evidence that internalized ligand/receptor
complexes can stimulate cAMP production after their inter-
nalization came from studies of two typical protein hormone
receptors: one by our group on the thyroid stimulating hormone
receptor (TSHR)13 and one by another group on the parathyroid
hormone (PTH) receptor14. These studies independently sug-
gested that GPCRs are able of inducing a second, persistent phase
of cAMP production once internalized. Importantly, recent data
suggest that signaling by internalized GPCRs is biologically
relevant21, 22, as it has been implicated in the regulation of gene
transcription22 or even in the ultimate biological effects of a
hormone21. However, the mechanisms linking GPCR signaling at
intracellular sites to these biological effects are insufﬁciently
understood23–26.
Most of the available information regarding the site of intra-
cellular GPCR signaling comes from experiments in which
receptors have been overexpressed in heterologous cell lines. In
these experiments, PTH14 and β2-adrenergic15 receptors have
been found to co-localize with Gs-proteins on early endosomes.
Moreover, a retrograde trafﬁcking of PTH and vasopressin V2
receptors to the trans-Golgi network (TGN) has been shown to
terminate cAMP signaling20, 27. These data, together with direct
evidence for the β2-adrenergic receptor using conformational
biosensors15, suggest early endosomes as the site of intracellular
cAMP signaling. However, since trafﬁcking mechanisms may
differ substantially among cell types and might be affected by the
level of expression of the receptor28, it remains to be demon-
strated whether the same mechanisms also operate on endogen-
ous receptors in their native context. Furthermore, important
differences might exist among individual receptors. Indeed, in our
initial study on the TSHR, we found, based on immuno-
ﬂuorescence, co-localization between internalized TSH/TSHR
complexes and Gs-protein in the Golgi/TGN13. This raises the
intriguing possibility that, besides on early endosomes, GPCR
signaling might also occur at other intracellular compartments.
In this study, we address these important questions by fol-
lowing the internalization/trafﬁcking of an endogenous receptor
in real time, using the TSHR in primary thyroid cells as a model,
while directly visualizing the intracellular sites of Gs-protein
activation and monitoring local cAMP/PKA signaling. We ﬁnd
that internalized TSHRs induce Gs-protein activation in a
retromer-coated compartment (RCC) that is an extension of the
TGN and mediates retrograde trafﬁcking to this organelle, which
is accompanied by a late phase of cAMP/PKA signaling at the
Golgi/TGN. Interfering with receptor internalization, retrograde
trafﬁcking or the organization of the Golgi/TGN impair nuclear
signaling in response to TSH. These data indicate a new potential
role for the TGN as a central hub for GPCR trafﬁcking and
signaling and provide a new mechanism to explain the cellular
effects of GPCR signaling at intracellular sites.
Results
Internalized TSHRs trafﬁc retrogradely to the TGN. To follow
in real-time trafﬁcking and signaling of endogenous TSHRs, we
developed a highly sensitive imaging approach29 based on
ﬂuorescently labeled TSH and highly inclined and laminated
optical sheet (HILO) illumination30. This method is especially
well suited to visualize trafﬁcking and signaling events inside
these cells, since they become ﬂat and particularly thin (~1–2 µm)
in culture13. Fluorescently labeled TSH, used to visualize TSH/
TSHR complexes, conserved its biological activity13 and bound
speciﬁcally to TSHRs expressed in human embryonic kidney
(HEK293) cells (Supplementary Fig. 1) as well as to endogenous
TSHRs in primary mouse thyroid cells (Fig. 1a and Supplemen-
tary Fig. 2). Immediately after stimulation of primary thyroid cells
for 10 min, the ﬂuorescent TSH was found on the plasma
membrane (Fig. 1a and Supplementary Fig. 2, arrowheads) as well
as inside intracellular vesicles/tubulovesicular strictures (Fig. 1a
and Supplementary Fig. 2).
We then transfected primary mouse thyroid cells with different
subcellular markers to characterize the compartment(s) involved
in trafﬁcking of the internalized TSH/TSHR complexes. Rab531
fused to GFP (Rab5-GFP) or a fragment of α-2,6-sialyl transferase
fused to RFP (ST-RFP)32 were used to identify early endosomes
or the TGN, respectively. In cells stimulated with ﬂuorescently
labeled TSH, the internalized TSH was initially found in early
endosomes (Fig. 1b), but it rapidly accumulated in perinuclear
tubulovesicular structures labeled by the TGN marker ST-RFP,
reaching ~60% of maximum already at 10 min (Fig. 1c, d and
Supplementary Movie 1). After 30 min, ~60% of all internalized
TSH was found in the TGN (Fig. 1c, d). This approach also
allowed us to follow in real time the trafﬁcking of TSH/TSHR
complexes to the TGN, which occurred via fusion of TSH-
containing vesicles with the tubulovesicular structures marked
with ST-RFP (Fig. 1e and Supplementary Movie 2). Experiments
performed in cells transfected with YFP-tagged TSHR (TSHR-
YFP) conﬁrmed that internalized TSH and TSHRs remained in
the same compartment for at least 30 min after stimulation
(Supplementary Fig. 3). Furthermore, to directly visualize the
internalized TSH and TSHRs in the TGN, we cotransfected
primary mouse thyroid cells with TSHR-YFP and ST-RFP, which
were stimulated with ﬂuorescently labeled TSH. The results
conﬁrmed the fast retrograde trafﬁcking of TSH/TSHR complexes
to the TGN (Fig. 1f). On the basis of the intensity and estimated
volume of the TSH-containing vesicles, we calculated a TSH
concentration in the lumen of the vesicles of ~ 800 nM
(Supplementary Fig. 4). Since TSH has an afﬁnity for its receptor
in the picomolar range (high-afﬁnity Kd= 169 pM)33, we deduce
that nearly all receptors in these vesicles should have TSH bound
to them.
Internalized TSHRs meet an intracellular pool of Gs-protein.
We then asked whether TSH/TSHR complexes and Gs-proteins
cointernalize or meet subsequently in intracellular compartments.
To answer this question, we performed a series of live-cell HILO
imaging experiments in primary mouse thyroid cells transfected
with a ﬂuorescently tagged Gαs subunit (Gs-YFP) and stimulated
with ﬂuorescently labeled TSH. Under basal conditions, the Gαs
subunit was found at the plasma membrane as well as on intra-
cellular vesicles (Fig. 2a, left); only a minor fraction of these were
early endosomes, visualized by cotransfection of Rab5-mCherry
(Fig. 2b, left). Immediately after stimulation with ﬂuorescent
TSH, TSH/TSHR complexes were present at the plasma mem-
brane (Fig. 2a, right) as well as on early endosomes (Fig. 2b,
right); however, we found no Gs-protein on those early endo-
somes containing the internalized TSH/TSHR complexes (Fig. 2b,
right). At the same time, TSH/TSHR complexes began to accu-
mulate in a dynamic perinuclear tubulovesicular compartment in
close association with the Gs-protein (Fig. 2c). The kinetics was
similar to that of TSH accumulation in the TGN, reaching already
~70% of maximum after 10 min, when ~30% of the internalized
TSH was found to co-localize with the Gs-protein (Fig. 2d). At a
closer look, co-localization between TSH/TSHR complexes and
the Gs-protein was observed on subdomains of this compartment.
Figure 2e shows a typical example, where the Gs-protein is pre-
sent on a protruding subdomain of an elongated membranous
structure, whereas TSH/TSHR complexes are present, as often,
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also in the remaining part. Trafﬁcking among these structures
typically occurred via fusion/splitting between two domains of the
same type, i.e., prevalently carrying TSH/TSHR complexes or Gs-
proteins (Fig. 2f and Supplementary Movie 3).
To better investigate the mechanisms involved in these
trafﬁcking events, we additionally visualized the retromer
complex, which mediates retrograde trafﬁcking of receptors and
other membrane proteins from the endosome to the TGN34–36.
To perform this task, the retromer complex segregates the
membrane proteins targeted to the TGN on membrane
subdomains of the endosome that eventually detach from it and
fuse with the TGN34–36. For this purpose, primary mouse thyroid
cells were cotransfected with Gs-YFP and ﬂuorescently tagged
retromer Vps29 subunit (Vps29-mCherry), followed by stimula-
tion with ﬂuorescently labeled TSH. We found that the
subdomains where the internalized TSH/TSHR complexes were
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co-localizing with the Gs-protein were characterized by the
presence of Vps29 (Fig. 2g). Virtually all structures in which
internalized TSH and the Gs-protein were simultaneously present
were Vps29 positive (~96% of total; Fig. 2h).
Altogether, these ﬁndings indicated that the internalized TSH/
TSHR complexes were selectively meeting the Gs-protein on
membrane domains deﬁned by the presence of retromer, which
we call ‘retromer-coated compartment’ (Fig. 2i). The RCC
comprises the retromer-coated domains found in the endosome
and the TGN, which are in continuous dynamic exchange to
mediate retrograde trafﬁcking from the endosome to the TGN.
Internalized TSHRs activate endogenous Gs-proteins at RCC.
To directly visualize activation of the endogenous Gs-protein, we
used a conformational biosensor15 based on a nanobody (Nb37)
that selectively recognizes the guanine nucleotide-free state of the
Gαs subunit37, 38. This biosensor resides in the cytosol under
resting conditions and translocates to membranes where Gs
activation occurs15. In these experiments, primary mouse thyroid
cells were transfected with the biosensor (Nb37-YFP) alone to
allow investigating the activation of endogenous Gs-proteins by
endogenous TSHRs. In basal conditions, the biosensor (Nb37-
YFP) was found to be cytosolic and partially located on the
plasma membrane as well as on intracellular membranes, pre-
sumably because of basal Gs-protein activity (Supplementary
Fig. 5; in subsequent images the cytosolic signal was suppressed to
improve visualization). Upon stimulation with ﬂuorescent TSH
and receptor internalization, the TSH-containing perinuclear
tubulovesicular structures recruited Nb37-YFP (Fig. 3a). This was
observed as an increase (~60%) in the number of Nb37-YFP-
positve structures over time (Fig. 3b). The effect was speciﬁc and
required clathrin-mediated receptor endocytosis, as it could be
prevented by pretreatment with the endocytosis inhibitor dyna-
sore39 (Fig. 3b), which efﬁciently blocked TSH/TSHR inter-
nalization in primary mouse thyroid cells (Supplementary Fig. 6).
Moreover, we succeeded in directly observing an enhancement of
the Nb37-YFP signal on Gs-protein-containing structures upon
arrival of TSH-containing ones (Fig. 3c, d and Supplementary
Movie 4)—note that on average the TSH intensity did not change
during the same time, ruling out artefacts due to movements
along the z-axis (Fig. 3d). In cells additionally transfected with
Vps29-mCherry, recruitment of Nb37-YFP was observed on
Vps29-postive subdomains (Fig. 3e), demonstrating that activa-
tion of Gs-protein was occurring in the RCC described in Fig. 2.
To further characterize the compartment where the inter-
nalized TSH/TSHR complexes activate the Gs-proteins, we
simultaneously expressed Nb37-SNAP (stained with the cell-
permeable benzylguanine derivative silicon-rhodamine, SiR) with
the early endosome marker Rab5-GFP, the endocytic recycling
compartment40 marker Rab11-GFP, or the TGN marker ST-
RFP41. Virtually no co-localization (i.e., <1% structures with
triple co-localization) was observed with Rab5 (Fig. 3f) or Rab11
(Fig. 3g), indicating that there was no relevant activation of Gs-
proteins on early endosomes or in the endocytic recycling
compartment. Instead, we observed the simultaneous presence of
internalized TSH/TSHR complexes and active Gs-protein on
membrane domains that belonged to the TGN or were intimately
associated with it (Fig. 3h, i; triple co-localization 34% at 20 min).
Also for this triple co-localization, the kinetics was similar to that
of TSH/TSHR accumulation in the TGN.
Taken together, the data presented in Figs. 1–3 indicated that
Gs-protein activation induced by internalized TSHRs was
occurring at a speciﬁc compartment deﬁned by the presence of
retromer, i.e., the RCC, which mediates retrograde trafﬁcking to
the TGN and is distinct from both early endosomes and the
endocytic recycling compartment (Fig. 3j).
PKA II in the Golgi/TGN promotes TSH nuclear signaling.
Based on these results, we set out to investigate the possible role
of TSHR/Gs-protein signaling at the RCC in mediating the bio-
logical effects of TSH at cellular level. We concentrated our efforts
on cAMP and its main effector PKA, which is a tetramer com-
posed of two regulatory (R) and two catalytic (C) subunits42. The
isoform of R subunit present plays a fundamental role in deﬁning
PKA speciﬁcity, by tethering the kinase to different subcellular
compartments via interaction with speciﬁc scaffold proteins
(AKAPs)43.
First, we evaluated the subcellular localization of the main PKA
subunits expressed in thyroid cells (Cα, RIα, RIIα, RIIβ)44 by
immunoﬂuorescence with speciﬁc antibodies and confocal
microscopy (Fig. 4a). RIIβ, which plays a crucial role in mediating
the nuclear effects of TSH44 (see also below), was selectively
localized on perinuclear tubulovesicular structures, consistent
with its known location on membranes of the Golgi/TGN. RIIα
showed a prevalent localization on the same type of perinuclear
tubulovesicular structures, which also contained a relevant
fraction of Cα. Co-staining with a speciﬁc markers conﬁrmed
the selective localization of RIIβ on membranes of the Golgi
(Fig. 4b and Supplementary Fig. 7a), which is particularly
extended in thyroid cells, and, to a lesser extent, of the TGN
(Fig. 4c and Supplementary Fig. 7b). The pattern of RIIβ and
GOLPH4 immunoﬂuorescence was clearly distinct from that of
Fig. 3 Internalized TSH/TSHRs activate the Gs-protein at the retromer-coated compartment (RCC) associated with the TGN. Primary mouse thyroid cells
were co-transfected with different combinations of Nb37-YFP (or -SNAP) and subcellular markers, followed by stimulation with ﬂuorescent TSH (TSH-594
or TSH-647) for 10min. a Recruitment of Nb37 to tubulovesicular structures containing internalized ﬂuorescent TSH-594 at 10 and 30min.
b Quantiﬁcation of the effect of TSH stimulation on the number of Nb37-positive (Nb37+) structures over time. Reported is the percent change
(mean± s.e.m.; n= 5/5 cells) over basal with or without (control) dynasore pretreatment (30min). Differences at individual time points were compared
using the Holm–Šídák test for multiple comparisons (black dots, P values). c Transient membrane recruitment of Nb37-YFP upon arrival of TSH-594-
carrying vesicles. Top, Two consecutive images of a time series showing an increase of the Nb37-YFP signal upon arrival of a TSH-carrying vesicle. Bottom,
Kymograph of the above time series generated along the indicated white line, showing two consecutive events of Nb37 recruitment (arrowheads). d
Quantitative analysis of events like those shown in c (mean± s.e.m.; n= 30). ****P< 0.0001 by Student’s t-test compared to intensity immediately before
the event. ns, statistically non-signiﬁcant. Note that while the Nb37 intensity increased, the TSH-594 intensity did not change, ruling out artefacts due to
movements along the z-axis. e Representative image of an Nb37-postive membranous structure, showing the asymmetrical localization of TSH-647, Nb37-
YFP and Vps29-mCherry, used to visualize the retromer complex. f, g Simultaneous visualization of TSH-594, Nb37-SNAP labeled with SiR (Nb37-SiR) and
Rab5-GFP or Rab11-GFP, showing lack of triple co-localization. h Simultaneous visualization of TSH-647, Nb37-YFP and the TGN marker ST-RFP. The insets
show examples of Nb37 recruitment on both ST-RFP-positive and negative structures. i Quantiﬁcation showing the percentage (mean± s.e.m.; n= 15 cells)
of TSH-containing structures co-localizing with Nb37-YFP and ST-RFP over time. j Schematic view of the results. Where appropriate, cell edges and
nucleus (N) are marked in white. Data in a, e–h are representative of 4, 3, 3, 3 and 5 independent experiments, respectively
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the endoplasmic reticulum marker calnexin (Supplementary
Fig. 8). A similar Golgi localization was found for RIIα (Fig. 4d).
We previously demonstrated in a well differentiated rat thyroid
cell line (FRTL5) that PKA II, and in particular the isoform
containing the RIIβ subunit (PKA-RIIβ), is required for the
induction of CREB phosphorylation and gene transcription upon
TSH stimulation44. To verify this critical role of PKA II in
primary mouse thyroid cells, we repeated similar experiments in
which we stimulated primary mouse thyroid cells with TSH in the
presence of cell-permeable cAMP analogs that inhibit either PKA
I or PKA II44. The results conﬁrmed that activation of PKA II is
required for the efﬁcient induction of CREB phosphorylation
(Fig. 4e). We also investigated the effect of PKA I/II inhibition on
gene transcription of two typical cAMP/PKA regulated early
genes in thyroid cells, i.e., nuclear receptor 4A1 (Nr4a1) and
nuclear receptor 4A3 (Nr4a3), which are part of the initial
transcriptional response to TSH that ultimately leads to increased
thyroid hormone production and cell replication44. Inhibition of
PKA II caused a signiﬁcant reduction of the early gene response
to TSH as compared to PKA I inhibition (Fig. 4f). Furthermore,
we interfered with the correct subcellular localization of PKA II
by treating the cells with a cell-permeable peptide (Ht31) that
inhibits RII binding to AKAPs44. Immunoﬂuorescence experi-
ments conﬁrmed a partial loss of PKA RIIβ association with the
Golgi in the presence of Ht31 as compared to control peptide
Ht31P (Fig. 4g, h). This was accompanied by an inhibition of the
TSH-dependent induction of CREB phosphorylation (Fig. 4i).
TSHRs induce late cAMP/PKA response at Golgi/TGN. We
then used ﬂuorescence resonance energy transfer (FRET) -based
sensors to monitor in real time (by epiﬂuorescence microscopy)
the cAMP and PKA responses to TSH stimulation in primary
mouse thyroid cells. At the end of each experiment, the cells were
stimulated with forskolin to maximally activate the FRET sensors
for normalization; the presence of a FRET response to forskolin
indicated that neither sensor was saturated by TSH (Supple-
mentary Fig. 9).
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Fig. 4 PKA II activation and localization at the Golgi/TGN are required for efﬁcient TSH-dependent CREB phosphorylation a Subcellular localization of PKA
subunits in primary mouse thyroid cells. The catalytic (Cα) and regulatory subunits (RIα, RIIα and RIIβ) of PKA were visualized by immunoﬂuorescence
with speciﬁc antibodies. Nuclei were stained with DAPI. b, c Co-staining of RIIβ with antibodies against GOLPH4 (b) and TGN46 (c), showing selective
localization of RIIβ subunit on membranes of Golgi and TGN, respectively. Left, Confocal images. Right, 3D reconstructions from confocal image stacks (see
Supplementary Fig. 7). d Co-staining of RIIα with GOLPH4, showing preferential localization of RIIα at the Golgi. e Western blot analysis of CREB
phosphorylation (Ser133) in response to TSH in cells pretreated for 1 h with a PKA I (Rp8-Br-cAMPS, 250 μM) or PKA II (Rp8-Br-PIP-cAMPS, 250 μM)
inhibitor. α-tubulin was used as loading control. Data (mean± S.E.M, n= 3) are expressed relative to those in the mock-stimulated sample pretreated with
PKA I inhibitor. f Induction of early genes in response to TSH in cells pretreated for 1 h with PKA I/II inhibitors. Data (mean± S.E.M, n= 4) are expressed as
in e. g Effect of Ht31 or Ht31P (control) peptides (20 μM, 1 h) on the Golgi localization of RIIβ. Shown are representative RIIβ and GOLPH4
immunoﬂuorescence stainings acquired with same contrast settings. h Quantiﬁcation of images as in g. RIIβ intensity values (mean± s.e.m., n= 12/20) are
expressed relative to those of GOLPH4. i Western blot analysis of CREB phosphorylation (Ser133) in cells pretreated for 1 h with Ht31 or Ht31P (20 μM)
and stimulated with TSH. Data (mean± s.e.m., n= 3) are expressed relative to those measured in the mock-stimulated control sample. Differences in e, f
and i are statistically signiﬁcant by two-way ANOVA. *P< 0.05, **P< 0.01, by Bonferroni’s post hoc test. Difference in h is statistically signiﬁcant by
unpaired t-test (***P< 0.001). ns, statistically non-signiﬁcant difference. Images in a–d and g are representative of 4, 3, 3, 5 and 3 independent
experiments, respectively
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First, we evaluated the kinetics of cAMP signaling in response
to TSH stimulation. In primary thyroid cells isolated from a
mouse transgenic for a cAMP FRET sensor (Epac1-camps)13, 45,
the cAMP response to TSH was apparently characterized by a
single phase (Fig. 5a, dark red), even though the kinetics was
complex as the resulting curve could be better ﬁtted with a three
phase model than with a simple mono-exponential one
(Supplementary Fig. 10a). Inhibiting TSH/TSHR internalization
with dynasore did not cause any signiﬁcant change in the overall
cAMP response (Fig. 5a, light red); however, the resulting curve
could be better ﬁtted with a mono-exponential model than the
control one (Supplementary Fig. 10b), consistent with a simpler
kinetics of cAMP accumulation. Moreover, the cAMP FRET
response to forskolin was not affected by dynasore pretreatment,
indicating that dynasore had no detrimental effects on cAMP
production (Supplementary Fig. 11a).
Then, we monitored PKA activation by transfecting primary
mouse thyroid cells with a FRET-based PKA sensor (AKAR2)46.
The PKA response to TSH stimulation was characterized by a
complex kinetics, with three consecutive phases discernible in
both averaged (Fig. 5b, dark green) and individual traces
(Supplementary Fig. 12a). In contrast to cAMP signaling,
dynasore pretreatment greatly impaired the PKA response at
late time points (>2 min). Whereas the ﬁrst phase was conserved,
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Fig. 5 TSHR internalization is associated with a late cAMP/PKA response at the Golgi/TGN. Primary thyroid cells isolated from Epac1-camps transgenic
mice or from wild-type mice and transfected with various FRET-based sensors were used to monitor cAMP and PKA responses in real time. Cells were
pretreated with or without (control) dynasore for 30min, followed by TSH stimulation. Data were normalized to the basal value (set to 0) and the maximal
response to forskolin at the end of each experiment (set to 1). Differences at individual time points were compared using the Holm-Šídák test for multiple
comparisons (black dots, P values). a cAMP FRET responses (mean± s.e.m.; n= 8/10) in primary thyroid cells isolated from Epac1-camps mice. b PKA
FRET responses (mean± s.e.m.; n= 11/7) in primary thyroid cells transfected with the ubiquitous AKAR2 sensor. Data were ﬁtted with a three phase
exponential model with delay (see Methods). c cAMP FRET responses (mean± s.e.m.; n= 4/5) in primary thyroid cells transfected with the Epac1-camps
sensor targeted to the plasma membrane (Epac1-CAAX). d PKA FRET responses (mean± s.e.m.; n= 11/10) in primary thyroid cells transfected with the
AKAR2 sensor targeted to the plasma membrane (AKAR2-CAAX). e cAMP FRET responses (mean± s.e.m.; n= 8/4) in primary thyroid cells transfected
with the Epac1-camps sensor targeted to the Golgi/TGN (Epac1-GRIP). f PKA FRET responses (mean± s.e.m.; n= 5/4) in primary thyroid cells transfected
with the AKAR2 sensor targeted to the Golgi/TGN (AKAR2-GRIP)
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the second and third phases were largely reduced and/or delayed/
slowed down (Fig. 5b, light green and Supplementary Table 1). At
the same time, the PKA FRET response to forskolin was not
affected by dynasore pretreatment, indicating that the effects of
dynasore were speciﬁc for TSHR-induced signaling as they could
be bypassed by directly activating adenylyl cyclases with forskolin
(Supplementary Fig. 11b). These results suggested that while the
receptors forced at the cell surface were still capable of inducing
efﬁcient cAMP generation, this was not sufﬁcient to induce a
normal PKA response.
We then sought to investigate where in the cell the different
phases of cAMP/PKA signaling where occurring. To this aim, we
generated Epac1-camps and AKAR2 sensors targeted to either the
plasma membrane (Epac1/AKAR2-CAAX, Fig. 5c, d) or the
Golgi/TGN (Epac1/AKAR2-GRIP, Fig. 5e, f), where PKA II is
predominantly located. Experiments performed with the plasma
membrane-tethered Epac1/AKAR2-CAAX sensors revealed that
TSH stimulation was causing a rapid increase of cAMP levels and
PKA activity at the plasma membrane that could not be
prevented by dynasore pretreatment (Fig. 5c, d), consistent with
the ﬁrst phase observed with the global AKAR2 sensor. In
contrast, experiments performed with the Golgi/TGN-tethered
Epac1/AKAR2-GRIP sensors, showed that cAMP levels and PKA
activity at the Golgi/TGN increased with a delay of ~7 and 9 min
after TSH stimulation, respectively (Fig. 5e, f). These late
responses at the Golgi/TGN were compatible with the kinetics
of TSH/TSHR retrograde trafﬁcking and Gs-protein activation at
the TGN as well as with the third phase observed with the global
AKAR2 sensor (Fig. 5b). Furthermore, the late Golgi/TGN
responses could be prevented by dynasore pretreatment, suggest-
ing that receptor internalization was required for cAMP/PKA
signaling at the Golgi/TGN (Fig. 5e, f).
TSHR internalization is required for TSH nuclear effects. We
then evaluated whether inhibiting TSHR internalization affected
the PKA-dependent phosphorylation of CREB and gene tran-
scription in response to TSH. Dynasore pretreatment prevented
the induction of CREB phosphorylation in primary mouse thyr-
oid cells (Fig. 6a). Consistently, dynasore pretreatment almost
completely blocked the induction of early genes (Fig. 6b).
TGN retrograde trafﬁcking promotes TSH nuclear signaling.
We then sought to investigate the functional consequences of
TSHR-dependent cAMP/PKA signaling at the Golgi/TGN in
thyroid cells. For this purpose, we ﬁrst perturbed Golgi/TGN
organization with Brefeldin A (BFA), which causes collapse of the
Golgi into the endoplasmic reticulum (ER), impairs anterograde
transport from the Golgi to the TGN and has been suggested to
induce tubulation of the upstream endosomal compartment47–49.
BFA pretreatment induced, as expected, disorganization of the
TGN and reduced/delayed the co-localization of internalized
TSH/TSHR complexes with the TGN marker ST-RFP, as shown
by live-cell HILO imaging (Fig. 7a; for comparison see Fig. 1c).
Immunoﬂuorescence revealed that BFA treatment also caused
dislocation of PKA RIIβ-subunit from the perinuclear region to
small vesicles scattered throughout the cytoplasm (Fig. 7b). PKA
RIIβ maintained some partial co-localization with TGN46,
whereas the strong co-localization with the Golgi marker
GOLPH4 was almost completely lost (Fig. 7b; for comparison see
Fig. 4b, c).
We then evaluated the effect of BFA on the cAMP and PKA
responses to TSH stimulation, measured by real-time FRET
microscopy. Pretreatment of primary mouse thyroid cells with
BFA signiﬁcantly attenuated the cAMP response at late time
points (>4 min) (Fig. 7c, light red), possibly because TSH/TSHRs
were partially trapped in an endosomal compartment devoid of
Gs-protein (and/or adenylyl cyclases). This was accompanied by a
partial reduction of the second and third phases of PKA
activation and apparently by a delay of the third phase, while
the ﬁrst one was not affected (Fig. 7d, light green; representative
individual trace in Supplementary Fig. 12b). In contrast, the
cAMP and PKA FRET responses to forskolin were not affected by
BFA pretreatment, indicating that the effects of BFA were speciﬁc
for TSHR-induced signaling as they could be bypassed by directly
activating adenylyl cyclases with forskolin (Supplementary
Fig. 11c, d).
Remarkably, BFA pretreatment almost completely prevented
the TSH-dependent induction of CREB phosphorylation (Fig. 7e),
similar to dynasore (Fig. 6a), suggesting that perturbing the
Golgi/TGN organization uncoupled cAMP/PKA signaling from
its nuclear effects.
In addition, we searched for a more speciﬁc way of inhibiting
the retrograde trafﬁcking of TSH/TSHR complexes. For this
purpose, we silenced the retromer subunit Vps35 using speciﬁc
siRNAs (Fig. 7f). The resulting partial reduction of Vps35 protein
levels (~65%) was accompanied by a signiﬁcant reduction of
CREB phosphorylation upon TSH stimulation (Fig. 7f).
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Altogether, these ﬁndings indicated that a correct organization
of the Golgi/TGN as well as the retromer-mediated retrograde
trafﬁcking to the TGN were required for efﬁcient CREB
phosphorylation in response to TSH (Fig. 7g).
Discussion
This study, which investigated endogenous TSHRs in primary
thyroid cells, provides evidence that an agonist-activated GPCR
can trafﬁc retrogradely to the TGN and activate the Gs-protein in
a retromer-coated compartment (RCC) that is both part of and
intimately associated with the TGN, being responsible for retro-
grade trafﬁcking from the endosome to the latter compartment34,
35. Indeed, the fact that the TGN and in particular its retromer-
coated subdomain is the only place where we simultaneously
observe the presence of internalized TSH/TSHR, active Gs-pro-
tein and PKA II tends to exclude other compartments and sug-
gests the TGN as the most likely critical site of signaling by
internalized TSHRs.
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Interestingly, we ﬁnd that TSHR internalization is accom-
panied by a late phase of local cAMP/PKA signaling at the Golgi/
TGN, with kinetics compatible with that of TSH/TSHR retro-
grade trafﬁcking. Moreover, we show that interfering with
receptor internalization, retrograde trafﬁcking, PKA II activation/
subcellular localization or Golgi/TGN organization all impair
efﬁcient CREB phosphorylation and/or gene transcription in
response to TSH. On the basis of these ﬁndings, we propose a
new model in which the internalized TSH/TSHR complexes
trafﬁc retrogradely to the TGN and induce local cAMP produc-
tion and activation of PKA II—which is localized on membranes
of the Golgi/TGN and is important for TSH nuclear effects—to
ultimately induce efﬁcient CREB phosphorylation in the nucleus
and gene transcription (Fig. 8). This model is fundamentally
different from the one put forward so far for PTH14 and β2-
adrenergic15 receptors, which have been shown to activate Gs-
proteins on early endosomes and cease doing so upon entering
the RCC27, 50. Indeed, we observed no Gs-protein activation on
early endosomes, a selective co-localization of internalized TSH/
TSH complexes and Gs-protein in the RCC, and, just opposite to
PTH receptors27, a positive role of retromer in promoting CREB
phosphorylation by internalized receptors. This indicates that the
subcellular location and mechanisms involved in TSHR signaling
after internalization are clearly distinct from those shown for
PTH and β2-adrenergic receptors.
The TGN plays an important role as a central hub for protein
trafﬁcking and sorting34. Interestingly, several key components of
the GPCR machinery, including G-proteins and adenylyl cyclases,
are abundant on intracellular membranes, above all of the Golgi/
TGN13, 23. While the presence of G-proteins on intracellular
membranes has been general linked to receptor-independent
roles in vesicular trafﬁcking23, 51, recent data suggest a possible
role of endosomal G-protein-mediated signaling in receptor
trafﬁcking52. PKA II is also predominantly tethered to mem-
branes of the Golgi/TGN, from where it can translocate to the
nucleus to regulate gene transcription44, 53. We previously
demonstrated that the expression of PKA II containing the RIIβ
subunit (PKA-RIIβ) and its correct subcellular localization
mediated by AKAPs are required for the TSH-dependent
induction of CREB phosphorylation and gene transcription44.
However, a direct link between GPCR signaling initiated at the
plasma membrane and PKA signaling at the Golgi/TGN as well as
a mechanism capable of explaining the requirement for such a
high degree of spatial organization were lacking54. The present
study provides an explanation for these ﬁndings by suggesting
that it is the receptor (and note vice versa) that together with its
ligand trafﬁcs to the TGN, where it activates resident Gs-proteins
and induces local cAMP/PKA signaling to ultimately trigger
nuclear effects. Altogether, these data point to the Golgi/TGN
having a key role in GPCR action, by providing a dynamic
platform that organizes all the components required for cAMP/
PKA signaling at a critical location near the nucleus.
In addition to providing a mechanism capable of explaining the
functional relevance of signaling by internalized TSHRs, the
present ﬁndings strongly support the hypothesis of cAMP/PKA
micro-compartmentalization5, 7–10. Remarkably, we show that
inhibiting receptor internalization with dynasore has no con-
sequences on the overall amplitude of the cAMP response but
prevents cAMP and PKA signaling at the Golgi/TGN as well as
Fig. 7 Interfering with retrograde trafﬁcking or Golgi/TGN organization impairs cAMP/PKA signaling and CREB phosphorylation. a Sequential HILO images
showing effect of BFA on TGN organization and TSH/TSHR retrograde trafﬁcking. Primary mouse thyroid cells were transfected with the TGN maker ST-
RFP. Thereafter, they were treated with BFA for 30min, stimulated with TSH-647 for 10min and imaged for additional 30min. b Immunoﬂuorescence
against RIIβ and either GOLPH4 (left) or TGN46 (right) in cells pretreated with BFA, showing displacement of the PKA RIIβ subunit from the Golgi and its
reduced association with the TGN, respectively. Images were acquired by confocal microscopy. Data in a and b are representative of 3 independent
experiments. c cAMP FRET responses (mean± s.e.m.; n= 9/13) in primary thyroid cells isolated from Epac1-camps mice pretreated with or without
(control) BFA for 30min. d PKA FRET responses (mean± s.e.m.; n= 11/11) in primary thyroid cells transfected with the AKAR2 sensor and pretreated with
or without (control) BFA. Data in c and d were normalized as in Fig. 5. Differences at individual time points were compared using the Holm–Šídák test for
multiple comparisons (black dots, P values). e Western blot analysis of CREB (Ser133) phosphorylation in primary thyroid cells stimulated with TSH with/
without BFA pretreatment. α-tubulin was used as loading control. Images are representative of 3 independent experiments. Data (mean± s.e.m., n= 3) are
expressed relative to those measured in the mock-stimulated control sample. f Western blot analysis of CREB (Ser133) phosphorylation in primary thyroid
cells transfected with Vps35 siRNA pool or control non-targeting siRNA and stimulated with TSH for 10min. α-tubulin was used as loading control. Images
are representative of six independent experiments. Data (mean± s.e.m., n= 6) are expressed relative to those measured in the mock-stimulated control
sample. Differences in e and f are statistically signiﬁcant by two-way ANOVA. *P< 0.05 by Bonferroni’s post hoc test. g Schematic view of the results
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Fig. 8 Model proposed for TSHR signaling at the TGN based on the results
of this study. Upon TSH stimulation, TSH/TSHR complexes internalize and
trafﬁc retrogradely to the TGN, leading to local Gs-protein activation in the
retromer-coated compartment (RCC) and cAMP/PKA signaling at the
Golgi/TGN, which is critically positioned near the nucleus. This appears
required for efﬁcient PKA-dependent CREB phosphorylation and the
induction of early genes in response to TSH, which in thyroid cells is known
to ultimately lead to increased thyroid hormone production and cell
proliferation
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the induction of CREB phosphorylation and gene transcription.
Moreover, altering the subcellular localization of PKA II via
interfering with binding to AKAPs also impairs CREB phos-
phorylation. In addition, we show that interfering with the
organization of the Golgi/TGN with BFA alters the kinetics of
PKA activation and prevents CREB phosphorylation. Con-
sistently, reducing retromer Vps35 subunit expression via siRNA
partially impairs CREB phosphorylation in response to TSH.
Taken together, these data suggest that what ultimately matters
are not just the amplitudes of the cAMP and PKA signals but also
their subcellular locations.
Another important ﬁnding of the present study is the direct
observation of three kinetically distinct waves of PKA activation.
This validates and further extends the idea of multiple waves of
intracellular GPCR signaling that was previously only hypothe-
sized24. On the basis of the results obtained with the plasma
membrane and Golgi/TGN-targeted PKA sensors, we assign the
ﬁrst and third of these phases to PKA activation at the plasma
membrane and at the Golgi/TGN, respectively. While we do not
possess direct information about the second phase, a number of
observations, including the fact that it precedes the Golgi/TGN
phase and that the only other place where we observe the
simultaneous presence of TSHR/Gs-protein and Gs-protein acti-
vation are retromer-coated domains associated with the TGN but
lacking the TGN-marker ST-RFP, it is conceivable that the sec-
ond phase occurs once the TSH/TSHR complexes enter the RCC
but prior to their arrival in the TGN.
Whereas we believe that that this study represents a signiﬁcant
advance as it investigates endogenous receptors and Gs-proteins
in their native cellular context and provides a new model to
explain the functional consequences of G-protein-dependent
signaling by internalized receptors at a cellular level, some lim-
itations must be considered. First, we deliberately focused on
early events within 30 min of TSH stimulation, i.e., induction of
CREB phosphorylation and early gene transcription, and short
pharmacological treatments (max. 1 h) to reduce possible indirect
effects of interfering with receptor internalization/trafﬁcking. This
is a crucial issue that currently severely limits our possibilities of
looking at long-term effects of GPCR signaling after internaliza-
tion and/or to perform experiments in vivo. Second, despite the
major advances represented by FRET and conformational bio-
sensors, it remains difﬁcult to directly localize the subcellular sites
of cAMP production and PKA activation in living cells with high
precision. Thus, the development of entirely new approaches and
tools as well as of appropriate animal models appear required to
investigate the physiological relevance of signaling by internalized
receptors in the future.
Using a conformational biosensor for the Gs-protein, the pre-
sent study was also able to capture the dynamic nature of Gs-
protein signaling at intracellular sites. Our results indicate that
Gs-protein activation at the RCC occurs in spikes with the arrival
of new vesicles carrying TSH/TSHR complexes. This is reminis-
cent of the very transient events of Gs-protein activation observed
for β2-adrenergic receptors at early endosomes15. Altogether,
these experiments reveal a quantal nature of GPCR signaling,
whereby each vesicle carrying a deﬁned amount of receptor and
ligand seemingly produces a temporally and spatially restricted
response.
Intriguingly, the present ﬁnding that TSHRs activate the Gs-
protein in the RCC, whereas some other GPCRs do so on early
endosomes14, 15, 27, 55—and not in the RCC50—points to the
existence of at least two distinct intracellular sites for signaling by
internalized GPCRs. Both receptor characteristics and cellular
context might ultimately dictate where and when a given receptor
is signaling after internalization. In this regard, the modality of
interaction with β-arrestin might also play an important role, as it
has been recently demonstrated that the vasopressin V2 but not
the β2-adrenergic receptor forms a stable supercomplex with the
Gs-protein and β-arrestin, which favors endosomal signaling56.
The requirement of TSHR internalization and retrograde traf-
ﬁcking to the TGN for efﬁcient nuclear signaling and the exis-
tence of multiple intracellular sites for GPCR signaling offer new
grounds to understand the cellular consequences of signaling by
internalized receptors, as well as to explain receptor speciﬁcity,
with important biological and pharmacological implications.
Methods
Animals. Wild-type or transgenic FVB mice expressing the Epac1-camps sensor
under control of the cytomegalovirus enhancer/chicken β-actin promoter13 were
used for the isolation of primary thyroid cells. All animal work was done according
to regulations of the relevant authority, the government of Lower Franconia,
Bavaria.
Reagents and suppliers. Cell culture reagents, collagenase I, collagenase II, goat
serum, Alexa Fluor 594 succinimidyl ester, Alexa Fluor 647 succinimidyl ester, goat
anti-rabbit Alexa Fluor 594-conjugated antibody (1:2,000), goat anti-mouse Alexa
Fluor 647-conjugated antibody (1:2,000) and TRIzol reagent were from Thermo
Fischer Scientiﬁc (Waltham, MA, USA). Dispase II, aprotinin, leupeptin and
cOmplete MINI protease inhibitor cocktail tablets were from Roche Diagnostics
(Mannheim, Germany). Trypsin/EDTA was from Pan Biotech (Aidenbach, Ger-
many). Brefeldin A, dynasore, phenylmethylsulfonyl ﬂuoride (PMSF), benzonase,
bovine TSH, anti-PKA RIIβ rabbit polyclonal antibody (cat. no. HPA008421;
1:100) and anti-α-tubulin mouse monoclonal antibody (cat. no. T9026; 1:40,000)
were from Sigma-Aldrich (Steinheim, Germany). Forskolin was from Tocris
(Bristol, UK). Fetal bovine serum was from Biochrom (Berlin, Germany). ECL
Prime Western Blotting Detection Reagent was from GE Healthcare (Buck-
inghamshire, UK). Mouse Accell SMARTpool Vps35 siRNA (cat. no. E-063309-00)
and non-targeting control siRNA (cat. no. D-001910-01-20) were purchased from
GE Healthcare Dharmacon (Lafayette, CO, USA). InCELLect AKAP St-Ht31
inhibitor peptide (cat. no. V821A) and St-Ht31P control peptide (cat. no. V822A)
were from Promega (Madison, WI, USA). PKA I-selective inhibitor 8-bromoade-
nosine-3′,5′-cyclic monophosphorothioate, Rp-isomer (Rp-8-Br-cAMPS) and PKA
II-selective inhibitor 8-piperidinoadenosine-3′,5′-cyclic monophosphorothioate,
Rp-isomer (Rp-8-PIP-cAMPS) were from BIOLOG (Bremen, Germany). SNAP-
Cell 647-SiR was purchased from New England BioLabs (Ipswitch, MA, USA).
Rabbit polyclonal antibodies against GOLPH4 (cat. no. 28049; 1:1,000) and TGN46
(cat. no. 16059; 1:1,000) as well as a goat polyclonal antibody against Vps35 (cat.
no. ab10099; 1:1,000) were from Abcam (Cambridge, UK). Anti-PKA Cα (cat. no.
610980; 1:100), RIα (cat. no. 610609; 1:100), RIIα (cat. no. 612242; 1:100) and RIIβ
(cat. no. 610625; 1:100) mouse monoclonal antibodies were from BD Biosciences
(Heidelberg, Germany). Anti-calnexin mouse monoclonal antibody (cat. no.
NB300-518; 1:100) was from Novus Biologicals (Wiesbaden, Germany). Anti-
phospho-CREB (Ser133) rabbit monoclonal antibody (cat. no. 4276; 1:1,000) was
from Cell Signaling Technology (Danvers, MA, USA). Goat anti-mouse and anti-
rabbit horseradish peroxidase (HRP) conjugated secondary antibodies (1:10,000)
and goat anti-mouse Cy2-conjugated polyclonal antibody (1:400) were from
Jackson ImmunoResearch (West Grove, PA, USA). All other chemicals were from
AppliChem (Darmstadt, Germany). TSH ﬂuorescently labeled with Alexa Fluor
594 (TSH-594) or Alexa Fluor 647 (TSH-647) was obtained as previously
described13.
Plasmids. A plasmid expressing the human wild-type TSHR tagged with EYFP
(TSHR-YFP) has been previously described57. A plasmid expressing a fragment (37
amino acids) of α-2,6-sialyltransferase fused C-terminally to monomeric RFP (ST-
RFP)41 was kindly provided by Enrique Rodriguez-Boulan (Cornell University,
New York, NY, USA). A plasmid expressing the Gαs subunit tagged with YFP
(Gαs-YFP) has been previously described58. A construct encoding His-tagged Nb37
was kindly provided by Jan Steyaert (VIB, Brussels, Belgium). Plasmids expressing
Nb37-EYFP or Nb37-SNAP were generated by fusing EYFP or SNAP sequences,
respectively, to the C-terminus of Nb37. Plasmids expressing Rab5 tagged with
GFP (Rab5-GFP) and mCherry (Rab5-mCherry) were kindly provided by Tom
Kirchhausen (Harvard Medical School, Boston, USA). A plasmid expressing EGFP-
tagged Rab1159 was kindly provided by Marino Zerial (Max Planck Institute of
Molecular Cell Biology and Genetics, Dresden, Germany). A plasmid expressing
YFP-tagged Vps29 (Vps29-YFP)60 was a gift from Juan Bonifacino (NICHD,
Bethesda, MA, USA). A plasmid expressing Vps29-mCherry was generated by
replacing YFP with mCherry in the original construct. A plasmid expressing the
plasma-membrane-targeted Epac1-CAAX sensor61 was kindly provided by Via-
cheslav O. Nikolaev (University Medical Center Hamburg-Eppendorf, Hamburg,
Germany). Plasmids expressing the AKAR246 and (cell membrane-targeted)
AKAR4-CAAX62 sensors were kindly provided by Jin Zhang (UCSD, San Diego,
CA, USA). A plasmid expressing the plasma membrane-targeted AKAR2-CAAX
sensor was generated by fusing the CAAX domain obtained from the latter plasmid
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to the C-terminus of AKAR2. Plasmid pCMV6-KL5-GolginA1, expressing the
Golgi/TGN-targeting GRIP domain of Golgin A1, was obtained from Origene. A
plasmid expressing the Golgi/TGN-targeted AKAR2-GRIP sensor was generated
by fusing the GRIP domain obtained from pCMV6-KL5-GolginA1 to the C-
terminus of AKAR2. A plasmid expressing the Golgi/TGN-targeted Epac1-GRIP
sensor was generated by replacing the AKAR2 sequence in the previous plasmid
with that of the Epac1-camps sensor.
Isolation and culture of primary mouse thyroid cells. Primary mouse thyroid
cells were prepared as described before13, 29. Brieﬂy, 2–4-month-old mice were
killed by cervical dislocation. The thyroid lobes were removed and suspended in a
1.5 ml tube containing Dulbecco’s modiﬁed Eagle’s medium (DMEM)/F12, sup-
plemented with 100 Uml−1 collagenase I, 100 Uml−1 collagenase II and 1 Uml−1
dispase II. Digestion was carried out for 90 min at 37 °C with gentle shaking every
15 min. Follicles were then washed three times with complete culture medium
(DMEM/F12 supplemented with 20% fetal bovine serum, 1% penicillin and 1%
streptomycin). Thereafter, they were plated onto 100-mm Petri dishes and main-
tained at 37 °C, 5% (vol/vol) CO2. Cells were cultured for 7–12 days in complete
culture medium before use. To investigate CREB phosphorylation and gene tran-
scription, cells were starved in DMEM/F12 without fetal bovine serum for 48 h
before stimulation.
HEK293 cell culture and transfection. HEK293 cells were from American Type
Culture Collection (ATCC). Cells were mycoplasma negative. Cells were cultured
in DMEM supplemented with 10% fetal bovine serum, 0.1 mg ml−1 streptomycin
and 100 Uml−1 penicillin at 37 °C, 5% (vol/vol) CO2. HEK293 cells were seeded at
a density of 2.5 × 105 cells per well onto six-well plates containing 24-mm round
glass coverslips and allowed to grow for 24 h, after which they were transfected
with the Effectene transfection kit (Qiagen) according to the manufacturer’s
protocol.
Electroporation of primary mouse thyroid cells. Electroporation of primary
mouse thyroid cells was performed as previously described29. Brieﬂy, cells were
resuspended in 120 µl Dulbecco’s phosphate-buffered saline (DPBS) and trans-
ferred to a 0.4-cm electroporation cuvette (Bio-Rad; Munich, Germany). 40 µg
DNA was then added to the cuvette and electroporation was performed using a
Bio-Rad Gene Pulser II electroporation system with a capacitance extender set on
0.32 kV and 125 µF. 1 ml warm complete culture medium was added immediately
after the electric discharge and the cells were seeded on 24-mm round glass cov-
erslips in six-well plates ﬁlled with complete culture medium.
SNAP labeling. Nb37-SNAP expressed in primary thyroid cells was labeled by
incubating the cells with 1 μM of a cell-permeable SNAP substrate (SNAP-Cell 647
SiR) for 20 min at 37 °C in complete culture medium supplemented with 1% (w/v)
bovine serum albumin (BSA). Cells were then washed three times using complete
culture medium with 5 min incubation between each wash.
Live-cell HILO imaging. 48 h post transfection, live-cell imaging was carried out
on a TIRF microscope (Leica AM TIRF) equipped with an EMCCD camera
(Cascade 512B, Roper Scientiﬁc; Tucson, AZ, USA) and solid-state lasers (488, 561,
594 and 635 nm). An oil-immersion objective (HCX PL APO 100 × /1.46) was used
for HILO. Transfected cells grown on 24-mm coverslips were imaged in an imaging
chamber containing complete culture medium without phenol red. The microscope
was equipped with an incubator to maintain the temperature at 37 °C. A quadruple
band ﬁlter set was used to achieve minimal delay (1 ms switching time) among
channels. Exposure time was 50–100 ms for each channel. Frames of image
sequences were acquired every 3 or 5 s as indicated.
For the visualization of TSH/TSHR complexes, cells were stimulated with
ﬂuorescently labeled TSH (6 μg ml−1 TSH-594 or 12 μg ml−1 TSH-647) for 10 min,
followed by three rapid washes with complete culture medium without phenol red.
Visualization was interrupted during this stimulation time, as the strong
ﬂuorescence of TSH in the medium prevented imaging.
Post-acquisition image analyses was carried out on ImageJ (https://imagej.nih.
gov/ij/). In experiments involving ﬂuorescent ligands, bleaching correction with the
Histogram method in ImageJ was performed. When indicated, a Fast Fourier
Transform bandpass ﬁlter was applied to the images to suppress the signal from the
cytosol. To improve visualization, images shown in insets were resized by a factor
of 5.0 using bicubic interpolation, without introducing any noticeable alteration
when compared at low magniﬁcation. For analyses based on quantiﬁcation of the
number of vesicles, a threshold was applied to the images and the vesicles were
automatically detected and counted using the Measure Particles function of ImageJ.
To estimate the percentage of vesicles with co-localization of two or more markers,
a binary mask was generated from the images acquired in the ﬁrst channel and was
used to calculate the percentage of vesicles that were also positive in the other
channel(s). Calculations were performed in MS-Excel.
TSH quantiﬁcation. Single-molecule microscopy of individual ﬂuorescently
labeled TSH molecules spotted on clean coverslips was used for calibration. The
analysis conﬁrmed the presence of 1-2 ﬂuorophores per TSH-594 molecule, con-
sistent with the spectrophotometrically determined degree of labeling. We calcu-
lated an average intensity of 400 a.u. at 100 ms exposure (or 4 a.u. ms−1 exposure)
for each TSH-594 molecule. We used this calibration to calculate the number of
TSH molecules contained in individual TSH-carrying vesicles from cells imaged by
HILO using the same settings (except for lower exposure time to avoid saturation
while maintaining linearity between the two measurements). In parallel, we esti-
mated the average volume of the vesicles based on their Feret diameters in 2D
(median volume= 0.3 μm3). From these data, we calculated a median concentra-
tion of 8.6 × 10−7 M.
Real-time FRET microscopy. Primary thyroid cells isolated from Epac1-camps
transgenic mice were plated on 24-mm round glass coverslips and used 48 h later
for FRET measurements. In experiments using other FRET sensors, 7–12day old
primary mouse thyroid cells isolated from wild-type FVB mice were electroporated
with plasmids expressing the sensors and imaged 48 h later. The AKAR2 sensor46
was preferred over the more recent AKAR4 version62, because we found AKAR2 to
perform better in primary mouse thyroid cells. Coverslips were mounted in an
imaging chamber and the cells were maintained in imaging buffer (137 mM NaCl,
5.4 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, pH 7.3). Imaging was
performed on an Axiovert 200 inverted microscope (Zeiss; Jena, Germany),
equipped with an oil-immersion objective (plan-NEOFLUAR 63×/1.25), a 505 dcxr
beam splitter (Visitron Systems; Puchheim, Germany), a high-speed poly-
chromator system (Visitron Systems) and an iXon Ultra EMCCD camera (Andor;
Belfast, UK). The experiments were carried out at 37 °C and were monitored with
MetaFluor 7 software (Molecular Devices; Sunnyvale, CA, USA). Images were
acquired every 5 s and FRET was calculated as the ratio between YFP emission at
535 nm and CFP emission at 480 nm with correction for spillover of CFP signal
into the YFP channel and for direct excitation of YFP63. For measurements using
the Epac1-camps sensor, in which FRET values are inversely related to cAMP
levels, the YFP/CFP ratio was inverted to allow direct comparison with PKA
measurements. cAMP and PKA FRET responses were normalized to the maximal
response of either FRET sensor obtained by treating the cells with the direct
adenylyl cyclase activator forskolin (10 μM) at the end of each experiment21.
Immunoﬂuorescence. Samples were ﬁxed with 4% paraformaldehyde for 15 min
at room temperature (RT) and permeabilized with 0.1% Triton X-100 in DPBS for
3 min at RT. Thereafter, the samples were blocked with 5% goat serum in DPBS for
1 h at RT and incubated with the indicated primary antibodies overnight at 4 °C.
Samples were then incubated with appropriate secondary antibodies (Cy2-con-
jugated anti-mouse, Alexa Fluor 594-conjugated anti-rabbit or Alexa Fluor 647-
conjugated anti-mouse) at RT for 2 h. Nuclei were stained with DAPI. Coverslips
were either mounted in 85% glycerol or stored at 4 °C in DPBS until imaging.
Confocal images were acquired on a TCS SP5 confocal microscope (Leica
Microsystems; Wetzlar, Germany) using an oil-immersion objective (HCX PL APO
63x/1.4).
Pharmacological inhibition of PKA I and II. For inhibition of PKA I or II, primary
mouse thyroid cells were preincubated with either a PKA I-selective (Rp-8-Br-
cAMPS) or a PKA II-selective (Rp-8-PIP-cAMPS) inhibitor for 1 h followed by
stimulation with TSH.
Retromer siRNA silencing. The retromer Vps35 subunit was silenced using a pool
of cell-permeable siRNAs against mouse Vps35 (Mouse Accell SMARTpool). A
non-targeting siRNA was used as control. Silencing was performed by incubating
the cells for 5 days with 1 μM siRNA in DMEM/F12 without fetal bovine serum.
Western blot analyses. Cells were washed with DPBS and directly lysed with lysis
buffer (5% sodium dodecyl sulphate, 125 mM Tris-HCl, pH 6.8, supplemented with
0.1 mM PMSF, 2 µg ml−1 aprotinin, 0.5 mg ml−1 leupeptin, cOmplete Mini protease
inhibitor cocktail) maintained at 95 °C. The cells were then collected with a rubber
scraper and transferred to a 1.5-ml tube. Benzonase (ﬁnal concentration 1 Uml−1)
was then added to the cell lysates followed by incubation at 4 °C for 1 h on a
horizontal shaker (maintained at 300 r.p.m.). The lysate was then sonicated for 30 s
and centrifuged at 20,000 g at 4 °C for 30 min. The supernatant was then trans-
ferred to a fresh 1.5-ml tube and stored at −80 °C until use.
Cell lysates were separated on 10% SDS polyacrylamide gels and transferred to
polyvinylideneﬂuoride membranes. Membranes were blocked in Tris-buffered
saline containing 1% Tween-20 and 5% BSA. For the analysis of CREB
phosphorylation, membranes were incubated with anti-phospho-CREB antibody
overnight at 4 °C, followed by incubation with anti-tubulin antibody for 1 h at RT.
Membranes were ﬁnally incubated with anti-mouse and anti-rabbit HRP-
conjugated secondary antibodies for 1 h at RT. For the analysis of Vps35
expression, membranes were incubated with anti-Vps35 antibody overnight at 4 °
C, followed by incubation with anti-goat HRP-conjugated secondary antibody for
1 h at RT. Membranes were treated with the ECL Prime Western Blotting
Detection Reagent for 1 min at RT and detection was performed on photographic
ﬁlms (FUJI Medical; Tokyo, Japan). Films were scanned at 1,200 dpi and
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densitometry analysis was performed using ImageJ. Uncropped immunoblot
images can be found in Supplementary Fig. 13.
Analysis of gene transcription by real-time PCR. Real-time PCR was performed
as previously described44. Brieﬂy, RNA was extracted by the acid guanidinium
thiocyanate-phenol-chloroform extraction method using the TRIzol reagent. RNA
concentration was measured on a Nanodrop 2000 spectrophotometer (Thermo
Fischer Scientiﬁc).
Single-stranded cDNA was synthesized using the SuperScript II Reverse
Transcriptase kit (Thermo Fisher Scientiﬁc), starting from 1 µg RNA for each
sample. The complementary RNA was then removed by adding 2 U RNase H per
sample and incubating for 20 min at 37 °C.
Quantitative PCR was performed with the SYBR Select Master Mix (Thermo
Fischer Scientiﬁc) on a C100 Real Time PCR system (Bio-Rad). Samples were
measured in triplicate and were normalized against β-actin expression. The ΔΔCT
method was used to calculate relative expression levels.
Statistics. Statistical analyses were performed using the Prism 6 software
(GraphPad Software, La Jolla, CA, USA). Values are given as mean ± s.e.m. Dif-
ferences between two groups were assessed by two-tailed Student’s t-test. Differ-
ences among three or more groups were assessed by one-way or two-way analysis
of variance (ANOVA), as appropriate, followed by Bonferroni’s post hoc test.
Differences between individual time points were evaluated using the Holm-Šídák
test for multiple comparisons. Differences were considered signiﬁcant for P values
< 0.05.
Data in Fig. 5b were ﬁtted using the following set of equations:
Y tð Þ ¼ A1 1 e
t
τ1
 
; t  Δt2
Y tð Þ ¼ A1 1 e
t
τ1
 
þ A2 1 e
tΔt2
τ2
 
;Δt2 < t <Δt3
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τ2
 
þ A3 1 e
tΔt3
τ3
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; t  Δt3
where Ai is the amplitude of each phase i (with i= 1, 2, 3), τi is the corresponding
time constant and Δti is the corresponding delay.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author upon reasonable request.
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